Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03347292
Title Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | DEU

Facility Status City State Zip Country Details
USC Norris Hospital and Clinics Los Angeles California 90033 United States Details
University of Florida Health Sciences Center Gainesville Florida 32608 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109-1023 United States Details
Universitätsklinikum Köln Köln Nordrhein-Westfalen 50937 Germany Details
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Rheinland-Pfalz 55131 Germany Details
*Shaded cells indicate that there was no data available from for the field